ZEPOSIA ONCE-DAILY OZANIMOD Trademark

Trademark Overview

On Tuesday, October 5, 2021, a trademark application was filed for ZEPOSIA ONCE-DAILY OZANIMOD with the United States Patent and Trademark Office. The USPTO has given the ZEPOSIA ONCE-DAILY OZANIMOD trademark a serial number of 97060574. The federal status of this trademark filing is FIRST EXTENSION - GRANTED as of Friday, June 28, 2024. This trademark is owned by Receptos LLC. The ZEPOSIA ONCE-DAILY OZANIMOD trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations for use in the treatment of leukemia, auto inflammatory disease, autoimmune disease, blood disease, cancer, multiple sclerosis, ulcerative colitis, arthritis, musculoskeletal and skin diseases; pharmaceutical preparations, namely, cytokine inhibitory drugs; pharmaceutical preparations that modulate the immune system; all of the foregoing being immunomodulators
zeposia once-daily ozanimod

General Information

Serial Number97060574
Word MarkZEPOSIA ONCE-DAILY OZANIMOD
Filing DateTuesday, October 5, 2021
Status730 - FIRST EXTENSION - GRANTED
Status DateFriday, June 28, 2024
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing3 - Illustration: Drawing or design which also includes word(s) / letter(s) / number(s)
Published for Opposition DateTuesday, November 7, 2023

Trademark Statements

Description of MarkThe mark consists of the term "ZEPOSIA" with a two stylized joined quadrilateral and triangle designs to the left with the term "once-daily" above the letters "ZE" and the wording "(OZANIMOD)" below it.
Goods and ServicesPharmaceutical preparations for use in the treatment of leukemia, auto inflammatory disease, autoimmune disease, blood disease, cancer, multiple sclerosis, ulcerative colitis, arthritis, musculoskeletal and skin diseases; pharmaceutical preparations, namely, cytokine inhibitory drugs; pharmaceutical preparations that modulate the immune system; all of the foregoing being immunomodulators
Pseudo MarkONCE DAILY
NOT AVAILABLE"ONCE-DAILY" AND "OZANIMOD"

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateFriday, October 29, 2021
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameReceptos LLC
Party Type20 - Owner at Publication
Legal Entity Type16 - Limited Liability Company
AddressPrinceton, NJ 08543
Party NameReceptos LLC
Party Type10 - Original Applicant
Legal Entity Type16 - Limited Liability Company
AddressNew York, NY 10016

Trademark Events

Event DateEvent Description
Friday, October 8, 2021NEW APPLICATION ENTERED
Friday, October 29, 2021NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Saturday, October 30, 2021NOTICE OF DESIGN SEARCH CODE E-MAILED
Friday, July 8, 2022ASSIGNED TO EXAMINER
Wednesday, July 20, 2022NON-FINAL ACTION WRITTEN
Wednesday, July 20, 2022NON-FINAL ACTION E-MAILED
Wednesday, July 20, 2022NOTIFICATION OF NON-FINAL ACTION E-MAILED
Thursday, January 19, 2023TEAS RESPONSE TO OFFICE ACTION RECEIVED
Thursday, January 19, 2023CORRESPONDENCE RECEIVED IN LAW OFFICE
Thursday, January 19, 2023TEAS/EMAIL CORRESPONDENCE ENTERED
Monday, February 6, 2023APPROVED FOR PUB - PRINCIPAL REGISTER
Tuesday, February 21, 2023WITHDRAWN FROM PUB - OG REVIEW QUERY
Wednesday, March 1, 2023PREVIOUS ALLOWANCE COUNT WITHDRAWN
Wednesday, March 1, 2023NON-FINAL ACTION WRITTEN
Tuesday, May 30, 2023CORRESPONDENCE RECEIVED IN LAW OFFICE
Wednesday, March 1, 2023NON-FINAL ACTION E-MAILED
Wednesday, March 1, 2023NOTIFICATION OF NON-FINAL ACTION E-MAILED
Tuesday, May 30, 2023TEAS RESPONSE TO OFFICE ACTION RECEIVED
Wednesday, May 31, 2023TEAS/EMAIL CORRESPONDENCE ENTERED
Saturday, July 8, 2023NON-FINAL ACTION WRITTEN
Saturday, July 8, 2023NON-FINAL ACTION E-MAILED
Saturday, July 8, 2023NOTIFICATION OF NON-FINAL ACTION E-MAILED
Tuesday, October 3, 2023TEAS RESPONSE TO OFFICE ACTION RECEIVED
Tuesday, October 3, 2023CORRESPONDENCE RECEIVED IN LAW OFFICE
Wednesday, October 4, 2023TEAS/EMAIL CORRESPONDENCE ENTERED
Thursday, October 5, 2023APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, October 18, 2023NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, November 7, 2023PUBLISHED FOR OPPOSITION
Tuesday, November 7, 2023OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, January 2, 2024NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Friday, June 28, 2024SOU TEAS EXTENSION RECEIVED
Friday, June 28, 2024SOU EXTENSION 1 FILED
Thursday, September 19, 2024TEAS CHANGE OF OWNER ADDRESS RECEIVED
Thursday, September 19, 2024APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Friday, June 28, 2024SOU EXTENSION 1 GRANTED
Friday, June 28, 2024NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, September 19, 2024TEAS CHANGE OF CORRESPONDENCE RECEIVED
Tuesday, December 24, 2024SOU TEAS EXTENSION RECEIVED

Related Keywords

ozanimod daily once zeposia disease pharmaceutical preparations inhibitory cytokine namely drugs diseases immune being